Effect of water extracts from Thesium chinense Tunczaninov and Prunella vulgaris L. on aromatase and cyclooxygenase activities

Korean Journal of Pharmacognosy

Volumn 35, Issue 2, 2004, Pages 147-151

  Nam, Kyung Soo ^a   Shon, Yun Hee ^a  

^a Dongguk University College of Medicine   (South Korea)

Author keywords

Aromatase; Breast cancer chemoprevention; Cyclooxygenase 2; Prunella vulgaris L; Thesium chinense Tunczaninov; Western blot

Indexed keywords

AMINOGLUTETHIMIDE; ANTIESTROGEN; AROMATASE INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PLANT EXTRACT; PROSTAGLANDIN SYNTHASE INHIBITOR; PRUNELLA VULGARIS EXTRACT; TAMOXIFEN; THESIUM CHINENSE EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER PREVENTION; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG ISOLATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; INHIBITION KINETICS; MEDICINAL PLANT; MICROSOME; NONHUMAN; PLACENTA; PRUNELLA; PRUNELLA VULGARIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THESIUM CHINENSE; WESTERN BLOTTING;

EID: 3042775010     PISSN: 02533073     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ries, L., Wingo, P. A., Miller, S. S., Howe, H., Weir, H. K., Rosenberg, H. M., Vernon, S. W., Cronin, K., and Edwards, B. K. (2000) The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 88: 2398-2424.
2. Zhou, C., Zhou, D., Esteban, J., Murai, J., Sitteri, P. K., Wilczynski, S., and Chen, S. (1996) Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction (RT-PCR). J. Steroid Biochem. Mol. Biol. 59: 163-171.
3. Lu, Q., Nakamura, J., Savinov, A., Yue, W., Weisz, J., Dabbs, D. J., Wolz, G., and Brodie, A. (1996) Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. Endocrinology 137: 3061-3077.
4. Brodie, A., Qing, L., and Nakamura, J. (1997) Aromatase in the normal breast and breast cancer. J. Streoid Biochem. Mol. Biol. 61: 281-286.
5. Kargman, S. L., O'Neill, G. P., Viekers, P. J., Evens, J. F., Mancini, J. A., and Jothy, S. (1995) Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 55: 2556-2559.
6. 2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators. Br. J. Cancer 72: 1412-1419.
7. Tan, W. C., Privett, S., and Goldyne, M. E. (1974) Studies of prostaglandins in rat mammary tumors induced by 7.12-dimethylbenzanthracene. Cancer Res. 34: 3229-3231.
8. Rolland, P. H., Martin, P. M., Jacquemier, J., Rolland, A., and Toga, M. (1980) Prostaglandin production is a maker of high metastatic potential for neoplastic cells. J. Natl. Cancer Inst. 64: 1061-1070.
9. Fisher, B., Costantino, J. P., Wickerham, D. L., Resmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., Daly, M., Wieand, S., Tan-Chiu, E., Ford, L., Wolmark, N., and other National Surgical Adjuvant Breast and Bowel Project Investigators (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Inst. 18: 1371-1388.
10. Santen, R., Yue, W., Naftolin, F., Mor, G., and Berstein, L. (1999) The potential of aromatase inhibitors in breast cancer prevention. Endocr. Relat. Cancer 6: 235-243.
11. Yates, R. A., Dowsett, M., Fisher, G. V., Selen, A., and Wyld, P. J. (1996) Arimidex (ZD1033): A selective, potent inhibitor of aromatase in postmenopausal female volunteers. Br. J. Cancer 73: 543-548.
12. Lubet, R. A., Steele, V. E., DeCoster, R., Bowden, C., You, M., Juliana, M. M., Eto, I., Kelloff, G. J., and Grubbs, C. J. (1998) Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model. Carcinogenesis 19: 1345-1351.
13. Thompson, E. A. Jr. and Siiteri, P. K. (1974) Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. J. Biol. Chem. 249: 5364-5372.
14. Kitawaki, J. O., Kim, T., Kanno, T., Noguchi, T., Yamamoto, T., and Okada, H. (1993) Growth suppression of MCF-7 human breast cancer cells by aromatase inhibitors: a new system for aromatase inhibitor screening. J. Steroid Biochem. Mol. Biol. 44: 667-690.
15. James, V. H. T., McNeill, J. M., Lai, L. C., Newton, C. J., Braunberg, H., Ghilchik, M., and Reed, M. J. (1987) Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies. Steroids 50: 269-279.
16. Miller, W. R., Mullen, P., Sourdaine, P., Watson, C., Dixon, J. M., and Telford, J. (1997) Regulation of aromatase activity within the breast. J. Steroid Biochem. Mol. Biol. 61: 193-202.
17. Simpson, E. R., Mahendroo, M. S., Means, G. D., Kilgore, M. W., Hinshelwood, M. M., Graham-Lorence, S., Amarneh, B., Ito, Y., Fisher, C. R., and Michael, M. D. (1994) Aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. Endocr. Rev. 15: 342-355.
18. Rolland, P. H., Martin, P. M., Jacquemier, J., Rolland, A., and Toga, M. (1980) Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J. Natl. Cancer Inst. 64: 1061-1070.
19. Fulton, A. M. and Heppner, G. H. (1985) Relationships of prostaglandin E and natural killer sensitivity to metastatic potential in murine mammary adenocarcinoma. Cancer Res. 45: 4779-4784.
20. Connolly, J. M., Liu, X. H., and Rose, D. P. (1996) Dietary linoleic acid-stimulated human breast cancer cell growth and metastasis in nude mice and their suppression by indomethacin, a cyclooxygenase inhibitor. Nutr. Cancer 25: 231-240.
21. Loll, P. J. and Garavito, R. M. (1994) The isoforms of cyclooxygenase: structure and function. Exp. Opin. Invest. Drugs 3: 1171-1180.